{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:34:39Z","timestamp":1792708479868,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013272","name":"Third Health Programme","doi-asserted-by":"publisher","award":["947598"],"award-info":[{"award-number":["947598"]}],"id":[{"id":"10.13039\/100013272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The EURO-NMD Registry collects data from all neuromuscular patients seen at EURO-NMD's expert centres. In-kind contributions from three patient organisations have ensured that the registry is patient-centred, meaningful, and impactful. The consenting process covers other uses, such as research, cohort finding and trial readiness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The registry has three-layered datasets, with European Commission-mandated data elements (EU-CDEs), a set of cross-neuromuscular data elements (NMD-CDEs) and a dataset of disease-specific data elements that function modularly (DS-DEs). The registry captures clinical, neuromuscular imaging, neuromuscular histopathology, biological and genetic data and patient-reported outcomes in a computer-interpretable format using selected ontologies and classifications. The EURO-NMD registry is connected to the EURO-NMD Registry Hub through an interoperability layer. The Hub provides an entry point to other neuromuscular registries that follow the FAIR data stewardship principles and enable GDPR-compliant information exchange. Four national or disease-specific patient registries are interoperable with the EURO-NMD Registry, allowing for federated analysis across these different resources.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Collectively, the Registry Hub brings together data that are currently siloed and fragmented to improve healthcare and advance research for neuromuscular diseases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-024-03059-3","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T09:03:06Z","timestamp":1707901386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9345-0953","authenticated-orcid":false,"given":"Antonio","family":"Atalaia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Wandrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawel","family":"Lalout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Tassoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A. C.","family":"\u2019t Hoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Athanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzie-Ann","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Sakellariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Paliouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"van der Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Kornblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janbernd","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Pareyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bassez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Blacas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Jacoupy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Eng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Plan\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Haberlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Brusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke G. J.","family":"Hoeijmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"de Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristl G.","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Paradas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Silani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Gyenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evy","family":"Reviers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalil","family":"Hamroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Vroom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns","family":"Lochmuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresinha","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"key":"3059_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3233\/JND-140045","volume":"2","author":"JCW Deenen","year":"2015","unstructured":"Deenen JCW, Horlings CGC, Verschuuren JJGM, Verbeek ALM, Van Engelen BGM. The Epidemiology of Neuromuscular Disorders: A Comprehensive Overview of the Literature. J Neuromuscul Dis. 2015;2:73\u201385.","journal-title":"J Neuromuscul Dis"},{"key":"3059_CR2","unstructured":"Parliament E. Directive 2011\/24\/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients' rights in cross-border healthcare, 2011. CELEX: EC. Available: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32011L0024&from=EN [Accessed 19\/04\/2022 2022]."},{"key":"3059_CR3","doi-asserted-by":"crossref","unstructured":"Boycott KM, Lau LP, Cutillo CM, Austin CP. International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases. EMBO Mol Med. 2019","DOI":"10.15252\/emmm.201910486"},{"key":"3059_CR4","doi-asserted-by":"crossref","unstructured":"Austin CP, Cutillo CM, Lau LPL, Jonker AH, Rath A, Julkowska D, Thomson D, Terry S. F, de Montleau B, Ardigo D, Hivert V, Boycott KM, Baynam G, Kaufmann P, Taruscio D, Lochmuller H, Suematsu M, Incerti C, Draghia-Akli R, Norstedt I, Wang L, Dawkins HJS, International Rare Diseases Research C, Future of rare diseases research 2017\u20132027: an IRDiRC perspective. Clin Transl Sci. 2018;, 11:21\u201327","DOI":"10.1111\/cts.12500"},{"key":"3059_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13023-017-0676-3","volume":"12","author":"V Heon-Klin","year":"2017","unstructured":"Heon-Klin V. European reference networks for rare diseases: what is the conceptual framework? Orphanet J Rare Dis. 2017;12:137.","journal-title":"Orphanet J Rare Dis"},{"key":"3059_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13023-019-1139-9","volume":"14","author":"MI Bellgard","year":"2019","unstructured":"Bellgard MI, Snelling T, Mcgree JM. RD-RAP: beyond rare disease patient registries, devising a comprehensive data and analytic framework. Orphanet J Rare Dis. 2019;14:176.","journal-title":"Orphanet J Rare Dis"},{"key":"3059_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1136\/ebmed-2016-110494","volume":"21","author":"NJ Halfpenny","year":"2016","unstructured":"Halfpenny NJ, Quigley JM, Thompson JC, Scott DA. Value and usability of unpublished data sources for systematic reviews and network meta-analyses. Evid Based Med. 2016;21:208\u201313.","journal-title":"Evid Based Med"},{"key":"3059_CR8","unstructured":"Orphanet. Rare disease registries in Europe, 2021. Orphanet. Available: https:\/\/www.orpha.net\/orphacom\/cahiers\/docs\/GB\/Registries.pdf [Accessed 21\/04\/2022 2022]"},{"key":"3059_CR9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.nmd.2014.03.005","volume":"24","author":"T Evangelista","year":"2014","unstructured":"Evangelista T, van Engelen B, Bushby K. 200th ENMC International Workshop \u201cEuropean reference networks: recommendations and criteria in the neuromuscular field\u201d, 18\u201320 October 2013, Naarden, The Netherlands. Neuromuscul Disord. 2014;24:537\u201345.","journal-title":"Neuromuscul Disord"},{"key":"3059_CR10","doi-asserted-by":"crossref","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'neal L, Mcleod L, Delacqua G, Delacqua F, Kirby J, Duda SN, Consortium RE. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019; 95, 103208","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"3059_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"3059_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-319-67144-4_5","volume":"1031","author":"R Thompson","year":"2017","unstructured":"Thompson R, Robertson A, Lochmuller H. Natural history, trial readiness and gene discovery: advances in patient registries for neuromuscular disease. Adv Exp Med Biol. 2017;1031:97\u2013124.","journal-title":"Adv Exp Med Biol"},{"key":"3059_CR13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/humu.22390","volume":"34","author":"CL Bladen","year":"2013","unstructured":"Bladen CL, Rafferty K, Straub V, Monges S, Moresco A, Dawkins H, Roy A, Chamova T, Guergueltcheva V, Korngut L, Campbell C, Dai Y, Bari\u0161i\u0107 N, Kos T, Brabec P, Rahbek J, Lahdetie J, Tuffery-Giraud S, Claustres M, Leturcq F, Ben Yaou R, Walter MC, Schreiber O, Karcagi V, Herczegfalvi A, Viswanathan V, Bayat F, de la Caridad Guerrero Sarmiento I, Ambrosini A, Ceradini F, Kimura E, van den Bergen JC, Rodrigues M, Roxburgh R, Lusakowska A, Oliveira J, Santos R, Neagu E, Butoianu N, Artemieva S, Rasic VM, Posada M, Palau F, Lindvall B, Bloetzer C, Karaduman A, Topalo\u011flu H, Inal S, Oflazer P, Stringer A, Shatillo AV, Martin AS, Peay H, Flanigan KM, Salgado D, von Rekowski B, Lynn S, Heslop E, Gainotti S, Taruscio D, Kirschner J, Verschuuren J, Bushby K, B\u00e9roud C, Lochm\u00fcller H. The TREAT-NMD duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia. Hum Mutat. 2013;34:1449\u201357.","journal-title":"Hum Mutat"},{"key":"3059_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3233\/JND-170280","volume":"4","author":"Z Koeks","year":"2017","unstructured":"Koeks Z, Bladen CL, Salgado D, Van Zwet E, Pogoryelova O, McMacken G, Monges S, Foncuberta ME, Kekou K, Kosma K, Dawkins H, Lamont L, Bellgard MI, Roy AJ, Chamova T, Guergueltcheva V, Chan S, Korngut L, Campbell C, Dai Y, Wang J, Barisic N, Brabec P, Lahdetie J, Walter MC, Schreiber-Katz O, Karcagi V, Garami M, Herczegfalvi A, Viswanathan V, Bayat F, Buccella F, Ferlini A, Kimura E, Van Den Bergen JC, Rodrigues M, Roxburgh R, Lusakowska A, Kostera-Pruszczyk A, Santos R, Neagu E, Artemieva S, Rasic VM, Vojinovic D, Posada M, Bloetzer C, Klein A, Diaz-Manera J, Gallardo E, Karaduman AA, Oznur T, Topaloglu H, El Sherif R, Stringer A, Shatillo AV, Martin AS, Peay HL, Kirschner J, Flanigan KM, Straub V, Bushby K, Beroud C, Verschuuren JJ, Lochmuller H. Clinical outcomes in duchenne muscular dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database. J Neuromuscul Dis. 2017;4:293\u2013306.","journal-title":"J Neuromuscul Dis"},{"key":"3059_CR15","doi-asserted-by":"publisher","first-page":"D1018","DOI":"10.1093\/nar\/gky1105","volume":"47","author":"S Kohler","year":"2019","unstructured":"Kohler S, Carmody L, Vasilevsky N, Jacobsen JOB, Danis D, Gourdine JP, Gargano M, Harris NL, Matentzoglu N, McMurry JA, Osumi-Sutherland D, Cipriani V, Balhoff JP, Conlin T, Blau H, Baynam G, Palmer R, Gratian D, Dawkins H, Segal M, Jansen AC, Muaz A, Chang WH, Bergerson J, Laulederkind SJF, Yuksel Z, Beltran S, Freeman AF, Sergouniotis PI, Durkin D, Storm AL, Hanauer M, Brudno M, Bello SM, Sincan M, Rageth K, Wheeler MT, Oegema R, Lourghi H, Della Rocca MG, Thompson R, Castellanos F, Priest J, Cunningham-Rundles C, Hegde A, Lovering RC, Hajek C, Olry A, Notarangelo L, Similuk M, Zhang XA, Gomez-Andres D, Lochmuller H, Dollfus H, Rosenzweig S, Marwaha S, Rath A, Sullivan K, Smith C, Milner JD, Leroux D, Boerkoel CF, Klion A, Carter MC, Groza T, Smedley D, Haendel MA, Mungall C, Robinson PN. Expansion of the human phenotype ontology (HPO) knowledge base and resources. Nucleic Acids Res. 2019;47:D1018\u201327.","journal-title":"Nucleic Acids Res"},{"key":"3059_CR16","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1002\/humu.23792","volume":"40","author":"R Thompson","year":"2019","unstructured":"Thompson R, Papakonstantinou Ntalis A, Beltran S, Topf A, De Paula Estephan E, Polavarapu K, \u2019t Hoen PAC, Missier P, Lochmuller H. Increasing phenotypic annotation improves the diagnostic rate of exome sequencing in a rare neuromuscular disorder. Hum Mutat. 2019;40:1797\u2013812.","journal-title":"Hum Mutat"},{"key":"3059_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13023-019-0998-4","volume":"14","author":"A Pechmann","year":"2019","unstructured":"Pechmann A, Konig K, Bernert G, Schachtrup K, Schara U, Schorling D, Schwersenz I, Stein S, Tassoni A, Vogt S, Walter MC, Lochmuller H, Kirschner J. SMArtCARE: a platform to collect real-life outcome data of patients with spinal muscular atrophy. Orphanet J Rare Dis. 2019;14:18.","journal-title":"Orphanet J Rare Dis"},{"key":"3059_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3233\/JND-200617","volume":"8","author":"J Slayter","year":"2021","unstructured":"Slayter J, Hodgkinson V, Lounsberry J, Brais B, Chapman K, Genge A, Izenberg A, Johnston W, Lochmuller H, O\u2019Ferrall E, Pfeffer G, Plamondon S, Rodrigue X, Schellenberg K, Shoesmith C, Stables C, Taillon M, Warman-Chardon J, Korngut L, O\u2019Connell C. A Canadian adult spinal muscular atrophy outcome measures toolkit: results of a national consensus using a modified delphi method. J Neuromuscul Dis. 2021;8:579\u201388.","journal-title":"J Neuromuscul Dis"},{"key":"3059_CR19","unstructured":"EURORDIS. Survey of the delay in diagnosis for 8 rare diseases in Europe (\u2018EURORDISCARE 2\u2019) 2007. Available: https:\/\/www.eurordis.org\/sites\/default\/files\/publications\/Fact_Sheet_Eurordiscare2.pdf [Accessed 24\/04\/2019 2019]."},{"key":"3059_CR20","unstructured":"EC. The building blocks to make rare disease treatments more common 2022. Available: https:\/\/ec.europa.eu\/research-and-innovation\/en\/horizon-magazine\/building-blocks-make-rare-disease-treatments-more-common [Accessed 10\/02\/2023 2023]."},{"key":"3059_CR21","doi-asserted-by":"publisher","first-page":"160018","DOI":"10.1038\/sdata.2016.18","volume":"3","author":"MD Wilkinson","year":"2016","unstructured":"Wilkinson MD, Dumontier M, Aalbersberg IJ, Appleton G, Axton M, Baak A, Blomberg N, Boiten JW, Da Silva Santos LB, Bourne PE, Bouwman J, Brookes AJ, Clark T, Crosas M, Dillo I, Dumon O, Edmunds S, Evelo CT, Finkers R, Gonzalez-Beltran A, Gray AJ, Groth P, Goble C, Grethe JS, Heringa J, \u2019t Hoen PA, Hooft R, Kuhn T, Kok R, Kok J, Lusher SJ, Martone ME, Mons A, Packer AL, Persson B, Rocca-Serra P, Roos M, Van Schaik R, Sansone SA, Schultes E, Sengstag T, Slater T, Strawn G, Swertz MA, Thompson M, van der Lei J, Van Mulligen E, Velterop J, Waagmeester A, Wittenburg P, Wolstencroft K, Zhao J, Mons B. The FAIR guiding principles for scientific data management and stewardship. Sci Data. 2016;3:160018.","journal-title":"Sci Data"},{"key":"3059_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13023-019-1123-4","volume":"14","author":"S Courbier","year":"2019","unstructured":"Courbier S, Dimond R, Bros-Facer V. Share and protect our health data: an evidence based approach to rare disease patients\u2019 perspectives on data sharing and data protection - quantitative survey and recommendations. Orphanet J Rare Dis. 2019;14:175.","journal-title":"Orphanet J Rare Dis"},{"key":"3059_CR23","unstructured":"JRC. Set of common data elements 2021. Available: https:\/\/eu-rd-platform.jrc.ec.europa.eu\/set-of-common-data-elements_en [Accessed 08\/02\/2023 2021]."},{"key":"3059_CR24","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/bib\/bbv011","volume":"16","author":"R Hoehndorf","year":"2015","unstructured":"Hoehndorf R, Schofield PN, Gkoutos GV. The role of ontologies in biological and biomedical research: a functional perspective. Brief Bioinform. 2015;16:1069\u201380.","journal-title":"Brief Bioinform"},{"key":"3059_CR25","doi-asserted-by":"publisher","first-page":"e026828","DOI":"10.1136\/bmjopen-2018-026828","volume":"9","author":"DJ Willison","year":"2019","unstructured":"Willison DJ, Trowbridge J, Greiver M, Keshavjee K, Mumford D, Sullivan F. Participatory governance over research in an academic research network: the case of diabetes action Canada. BMJ Open. 2019;9:e026828.","journal-title":"BMJ Open"},{"key":"3059_CR26","doi-asserted-by":"crossref","unstructured":"Lawson J, Cabili MN, Kerry G, Boughtwood T, Thorogood A, Alper P, Bowers SR, Boyles RR, Brookes AJ, Brush M, Burdett T, Clissold H, Donnelly S, Dyke SOM, Freeberg MA, Haendel MA, Hata C, Holub P, Jeanson F, Jene A, Kawashima M, Kawashima S, Konopko M, Kyomugisha I, Li H, Linden M, Rodriguez LL, Morita M, Mulder N, Muller J, Nagaie S, Nasir J, Ogishima S, Ota Wang V, Paglione LD, Pandya RN, Parkinson H, Philippakis AA, Prasser F, Rambla J, Reinold K, Rushton GA, Saltzman A, Saunders G, Sofia HJ, Spalding JD, Swertz MA, Tulchinsky I, Van Enckevort EJ, Varma S, Voisin C, Yamamoto N, Yamasaki C, Zass L, Guidry Auvil JM, Nyronen TH, Courtot M. The Data Use Ontology to streamline responsible access to human biomedical datasets. Cell Genom. 2021; 1.","DOI":"10.1016\/j.xgen.2021.100028"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03059-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03059-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03059-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T09:03:52Z","timestamp":1707901432000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03059-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3059"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03059-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,14]]},"assertion":[{"value":"12 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no patient data at this stage. The ethical and legal advisory team, represented in this paper by Laura Blacas and Carla D\u2019Angelo, dealt with ethical and legal issues of the Registry. Recruitment will start after all the requirements have been met.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed the manuscript and consented to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Adrian Tassoni, Antonio Atalaia, Carla D\u2019Angelo, Catherine Eng, Dagmar Wandrei, Dalil Hamroun, Dimitrios Athanasiou, Elizabeth Vroom, Esther Brusse, Evy Reviers, Fran\u00e7ois Lamy, Georgios Paliouras, Hadrien Delattre, Jean-Philippe Plan\u00e7on, Laura Blacas, Maxime Jacoupy, Michelangelo Mancuso, Nawel Lalout, Paraskevi Sakellariou, Peter-Bram \u2019t Hoen, Rachel Thompson, Rita Horvath, Suzie-Ann Baker, Teresinha Evangelista declared no conflicts of interest. Antonio Toscano: Reimbursements for participation to scientific boards and for educational activities from Sanofi Genzyme, Amicus, Astellas, Bayer, Aro and Spark. Carmen Paradas: Advisory Board honoraria from UCB, Alexion, Sanofi-Genzyme. Cornelia Kornblum: Travel funding and\/or speaker honoraria from Chiesi, Amicus Therapeutics, Fulcrum Therapeutics, Novartis, Sanofi Genzyme, Santhera and acknowledges financial support as advisory board member and\/or primary investigator for Amicus Therapeutics, Fulcrum Therapeutics, Hormosan, Reneo Pharmaceuticals, Roche Pharma AG, Sanofi Genzyme, Stealth BioTherapeutics. Davide Pareyson: Financial support from Alnylam and Kedrion for participation in international meetings, participation in Advisory Boards of Inflectis, Alnylam, Akcea, Arvinas, Augustine Tx, DTx, speaker honorarium from Alnylam. Guillaume Bassez: Research funding from AFM-Telethon and compensation for consulting services and\/or speaking activities from Biogen, Dyne therapeutics, Lupin Pharmaceutical. Hanns Lochmuller: Support from the Canadian Institutes of Health Research (Foundation Grant FDN-167281), the Canadian Institutes of Health Research and Muscular Dystrophy Canada (Network Catalyst Grant for NMD4C), the Canada Foundation for Innovation (CFI-JELF 38412), and the Canada Research Chairs program (Canada Research Chair in Neuromuscular Genomics and Health, 950\u2013232279). Jana Haberlova: Honoraria as a advisory board members or speaker for Roche,Novartis, Biogen, PTC. Janbernd Kirschner: Consultancy and\/or speaker honoraria from Biogen, Novartis, Pfizer and Roche and research grants from Biogen, Novartis, Roche. Janneke G. J. Hoeijmakers: Grants from the Prinses Beatrix Spierfonds (W.OK17-09 and W.TR22-01). Kristl G. Claeys: Speaker\/Advisory board honoraria from Alexion, Alnylam, Amicus, ArgenX, Biogen, CSL Behring, Ipsen, Janssen Pharmaceutics, Lupin, Pfizer, Roche, Sanofi-Genzyme, UCB; and Research funding from CSL Behring (Chair), Alnylam, Biogen, Pfizer, Roche, Sanofi-Genzyme. Marianne de Visser: Consultancy honoraria from Novartis and Argenx. Mark D Wilkinson: Co-Founder of FAIR Data Systems S.L., Madrid, who were contracted to do some portions of the work with several of the registries described in this paper. Melinda Gyenge: Research funding from AFM-Telethon. Nadine van der Beek: Advisory boards of Sanofi, and Amicus Therapeutics. She received speaker honoraria Sanofi. Vincenzo Silani: Compensation for consulting services and\/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., Novartis Pharma AG and Zambon. He receives or has received research supports form the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call. He is in the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, European Neurology, American Journal of Neurodegenerative Diseases, Frontiers in Neurology, and Exploration of Neuroprotective Therapy.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}